Check
adisinsight.springer.com

Adisinsight.springer.com: Home - AdisInsight Online

Adisinsight.springer.com: visit the most interesting Adis Insight Springer pages, well-liked by users from China and USA, or check the rest of adisinsight.springer.com data below. Adisinsight.springer.com is a web project, safe and generally suitable for all ages. Their most used social media is Twitter with about 66% of all user votes and reposts.

Last check

adisinsight.springer.com most visited pages

  • Rovalpituzumab tesirine - AdisInsight

    Stemcentrx is developing rovalpituzumab tesirine (SC16LD6.5), an antibody-drug conjugate, for the treatment of several types of advanced solid tumours,

  • Daclizumab - AdisInsight

    Daclizumab is a human IgG1 monoclonal antibody that is being jointly developed by AbbVie and Biogen (formerly Biogen Idec) as a once-monthly subcutaneous

  • Home - AdisInsight

    Access the latest information Quickly identify what is important Our expert editors read, assess, summarize, and index information to make it easy to find and analyze S...

Social media reactions

SERVER network INFO

adisinsight.springer.com

146.75.32.95

Hosting provider:

Fastly, Inc.

DOMAIN

Registrar: EuroDNS S.A.
Registrant: Schipper Jaap (Springer Nature B.V.)
Updated: May 22, 2023
Expires: May 27, 2024
Created: May 28, 2009

WHOIS DATA